How and why does radioimmunotherapy work?

被引：21

作者：

Macklis, RM ^{[1
]}

机构：

[1] Cleveland Clin Fdn, Dept Radiat Oncol, Cleveland, OH 44195 USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2004年 / 59卷 / 05期

关键词：

D O I：

10.1016/j.ijrobp.2004.04.008

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1269 / 1271

页数：3

共 7 条

[1] Radiobiology of radioimmunotherapy: Targeting CD20 B-cell antigen in non-Hodgkin's lymphoma [J].

Hernandez, MC ;

Knox, SJ .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (05) :1274-1287

[2] Iodine-131 - Anti-B1 radioimmunotherapy for B-cell lymphoma [J].

Kaminski, MS ;

Zasadny, KR ;

Francis, IR ;

Fenner, MC ;

Ross, CW ;

Milik, AW ;

Estes, J ;

Tuck, M ;

Regan, D ;

Fisher, S ;

Glenn, SD ;

Wahl, RL .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (07) :1974-1981

[3]

Koral KF, 2003, J NUCL MED, V44, P1541

[4] Radium and its therapeutic effects [J].

Mcintyre, J .

BMJ-BRITISH MEDICAL JOURNAL, 1903, 1903 :1524-1526

[5] Radioimmunotherapy for non-Hodgkin's lymphomas: A historical perspective [J].

Press, OW .

SEMINARS IN ONCOLOGY, 2003, 30 (02) :10-21

[6] Paul Ehrlich's magic bullets. [J].

Schwartz, RS .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (11) :1079-1080

[7] Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma [J].

Witzig, TE ;

Gordon, LI ;

Cabanillas, F ;

Czuczman, MS ;

Emmanouilides, C ;

Joyce, R ;

Pohlman, BL ;

Bartlett, NL ;

Wiseman, GA ;

Padre, N ;

Grillo-López, AJ ;

Multani, P ;

White, CA .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) :2453-2463

← 1 →